Detalhe da pesquisa
1.
Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma.
Int J Mol Sci
; 23(13)2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806460
2.
Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.
BMC Cancer
; 19(1): 724, 2019 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331295
3.
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.
Oncol Res Treat
; 42(7-8): 396-404, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170709
4.
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors.
Clin Cancer Res
; 25(2): 609-618, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30274985
5.
Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Mol Cancer Ther
; 18(6): 1168-1178, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962320
6.
PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors.
Clin Exp Med
; 19(2): 201-210, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523507
7.
Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.
Oncol Res Treat
; 41(4): 206-213, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562223
8.
Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.
Oncol Res Treat
; 40(6): 353-359, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28501860
9.
In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models.
Mol Cancer Ther
; 16(8): 1566-1575, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566438
10.
Biology and management of clear cell sarcoma: state of the art and future perspectives.
Expert Rev Anticancer Ther
; 16(8): 839-45, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27253849
11.
Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations.
Mol Cancer Ther
; 15(12): 2845-2852, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27777285
12.
Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease.
Oncol Res Treat
; 37(6): 355-62, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903768
13.
Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors.
Clin Sarcoma Res
; 4: 10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132955
14.
Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models.
Transl Oncol
; 7(6): 665-71, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500074
15.
Left atrial myxoma on FDG-PET/CT.
Clin Nucl Med
; 38(11): e421-2, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510877